Pos | No | Age | Sex | Organ_Anatomic_Site | Pathology_diagnosis | Grade | TNM | Stage | Type | Tumor Size |
A1 | 1 | 35 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2N0M0 | II | Malignant | * |
A2 | 2 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | * |
A3 | 3 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
A4 | 4 | 38 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
A5 | 5 | 49 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 5*5 |
A6 | 6 | 47 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 9*9 |
A7 | 7 | 56 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 3*2.5*1.2 |
A8 | 8 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 6*4*4 |
A9 | 9 | 54 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2.5*2*0.5 |
A10 | 10 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 11*10*4 |
A11 | 11 | 37 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 6*4.5*3 |
A12 | 12 | 53 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 1 | T1aN0M0 | IA | Malignant | 9*8*8 |
A13 | 13 | 68 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 7*4*4 |
A14 | 14 | 54 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 2*1.5*1 |
A15 | 15 | 43 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 8*7*6 |
B1 | 16 | 35 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2N0M0 | II | Malignant | * |
B2 | 17 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | * |
B3 | 18 | 57 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
B4 | 19 | 38 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | * |
B5 | 20 | 49 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 5*5 |
B6 | 21 | 47 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 9*9 |
B7 | 22 | 56 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 3*2.5*1.2 |
B8 | 23 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 6*4*4 |
B9 | 24 | 54 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2.5*2*0.5 |
B10 | 25 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 11*10*4 |
B11 | 26 | 37 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 6*4.5*3 |
B12 | 27 | 53 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 1 | T1aN0M0 | IA | Malignant | 9*8*8 |
B13 | 28 | 68 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 7*4*4 |
B14 | 29 | 54 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 2*1.5*1 |
B15 | 30 | 43 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 8*7*6 |
C1 | 31 | 49 | F | Uterus | Endometrioid adenocarcinoma (atypical hyperplasia) | * | T1aN0M0 | IA | Malignant | 2.5*1 |
C2 | 32 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 4*2 |
C3 | 33 | 43 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2*2 |
C4 | 34 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2N0M0 | II | Malignant | 9*9*4 |
C5 | 35 | 37 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 4*3*1.5 |
C6 | 36 | 33 | F | Uterus | Endometrioid adenocarcinoma | 1--2 | T1bN0M0 | IB | Malignant | 11*9*4 |
C7 | 37 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*3.5 |
C8 | 38 | 70 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN1M0 | IIIC1 | Malignant | 6*4*4 |
C9 | 39 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 4*3*2 |
C10 | 40 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 3.5*2*0.8 |
C11 | 41 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | 3*2 |
C12 | 42 | 30 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
C13 | 43 | 57 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
C14 | 44 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
C15 | 45 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
D1 | 46 | 49 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2.5*1 |
D2 | 47 | 50 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 4*2 |
D3 | 48 | 43 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1aN0M0 | IA | Malignant | 2*2 |
D4 | 49 | 53 | F | Uterus | Endometrioid adenocarcinoma | 1 | T2N0M0 | II | Malignant | 9*9*4 |
D5 | 50 | 37 | F | Uterus | Endometrioid adenocarcinoma | 1 | T1bN0M0 | IB | Malignant | 4*3*1.5 |
D6 | 51 | 33 | F | Uterus | Endometrioid adenocarcinoma | 1--2 | T1bN0M0 | IB | Malignant | 11*9*4 |
D7 | 52 | 56 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*3.5 |
D8 | 53 | 70 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN1M0 | IIIC1 | Malignant | 6*4*4 |
D9 | 54 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 4*3*2 |
D10 | 55 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 3.5*2*0.8 |
D11 | 56 | 61 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | 3*2 |
D12 | 57 | 30 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
D13 | 58 | 57 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | * |
D14 | 59 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
D15 | 60 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
E1 | 61 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
E2 | 62 | 74 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1bN0M0 | IB | Malignant | 3*3*2 |
E3 | 63 | 59 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 8*3*2.5 |
E4 | 64 | 54 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 2 | T2N0M0 | II | Malignant | 2.5*2*1 |
E5 | 65 | 56 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1aN0M0 | IA | Malignant | 6*4.5*1.5 |
E6 | 66 | 70 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T2N0M0 | II | Malignant | 1.5*4.5*2 |
E7 | 67 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 4*3*2 |
E8 | 68 | 68 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3aN0M0 | IIIA | Malignant | 8*6*4 |
E9 | 69 | 54 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1aN0M0 | IA | Malignant | 9*5*3 |
E10 | 70 | 50 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3aN0M0 | IIIA | Malignant | 6*4*2.5 |
E11 | 71 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*3*3 |
E12 | 72 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 7*3*3 |
E13 | 73 | 79 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | 4*3*0.8 |
E14 | 74 | 60 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*5*3 |
E15 | 75 | 63 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T3aN0M0 | IIIA | Malignant | 9*3*2.5 |
F1 | 76 | 46 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | * |
F2 | 77 | 74 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 3*3*2 |
F3 | 78 | 59 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 8*3*2.5 |
F4 | 79 | 54 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | 2.5*2*1 |
F5 | 80 | 56 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1aN0M0 | IA | Malignant | 6*4.5*1.5 |
F6 | 81 | 70 | F | Uterus | Endometrioid adenocarcinoma | 2 | T2N0M0 | II | Malignant | 1.5*4.5*2 |
F7 | 82 | 52 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1bN0M0 | IB | Malignant | 4*3*2 |
F8 | 83 | 68 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3aN0M0 | IIIA | Malignant | 8*6*4 |
F9 | 84 | 54 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2 | T1aN0M0 | IA | Malignant | 9*5*3 |
F10 | 85 | 50 | F | Uterus | Endometrioid adenocarcinoma | 2 | T3aN0M0 | IIIA | Malignant | 6*4*2.5 |
F11 | 86 | 58 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*3*3 |
F12 | 87 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 7*3*3 |
F13 | 88 | 79 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1aN0M0 | IA | Malignant | 4*3*0.8 |
F14 | 89 | 60 | F | Uterus | Endometrioid adenocarcinoma | 2 | T1bN0M0 | IB | Malignant | 5*5*3 |
F15 | 90 | 63 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T3aN0M0 | IIIA | Malignant | 9*3*2.5 |
G1 | 91 | 58 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T1bN0M0 | IB | Malignant | 10*9*7 |
G2 | 92 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1bN1M0 | IIIC1 | Malignant | * |
G3 | 93 | 43 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T1bN0M0 | IB | Malignant | * |
G4 | 94 | 48 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1aN0M0 | IA | Malignant | * |
G5 | 95 | 43 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1aN0M0 | IA | Malignant | * |
G6 | 96 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1aN0M0 | IA | Malignant | 3*2.5*1 |
G7 | 97 | 53 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T1bN0M0 | IB | Malignant | 7*6*1.3 |
G8 | 98 | 58 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3N1M0 | IIIC1 | Malignant | 3*2 |
G9 | 99 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN1M0 | IIIC1 | Malignant | * |
G10 | 100 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 6*4.5*1 |
G11 | 101 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 6*4.5*1 |
G12 | 102 | 42 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3.0*1 |
G13 | 103 | 48 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | * |
G14 | 104 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | * |
G15 | 105 | 38 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 5*4*3 |
H1 | 106 | 58 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T1bN0M0 | IB | Malignant | 10*9*7 |
H2 | 107 | 52 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1bN1M0 | IIIC1 | Malignant | * |
H3 | 108 | 43 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 2--3 | T1bN0M0 | IB | Malignant | * |
H4 | 109 | 48 | F | Uterus | Endometrioid adenocarcinoma with squamous metaplasia | 2--3 | T1aN0M0 | IA | Malignant | * |
H5 | 110 | 43 | F | Uterus | Endometrioid adenocarcinoma (necrosis) | * | T1aN0M0 | IA | Malignant | * |
H6 | 111 | 42 | F | Uterus | Endometrioid adenocarcinoma | 2--3 | T1aN0M0 | IA | Malignant | 3*2.5*1 |
H7 | 112 | 53 | F | Uterus | Endometrioid adenocarcinoma (sparse) | 2--3 | T1bN0M0 | IB | Malignant | 7*6*1.3 |
H8 | 113 | 58 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3N1M0 | IIIC1 | Malignant | 3*2 |
H9 | 114 | 45 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN1M0 | IIIC1 | Malignant | * |
H10 | 115 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 6*4.5*1 |
H11 | 116 | 54 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 6*4.5*1 |
H12 | 117 | 42 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3.0*1 |
H13 | 118 | 48 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | * |
H14 | 119 | 45 | F | Uterus | Endometrioid adenocarcinoma (interstitial) | * | T1aN0M0 | IA | Malignant | * |
H15 | 120 | 38 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 5*4*3 |
I1 | 121 | 64 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1aN0M0 | IA | Malignant | 4*4 |
I2 | 122 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3*2*1 |
I3 | 123 | 49 | F | Uterus | Endometrioid adenocarcinoma | 3 | T2N0M0 | II | Malignant | 5*5*4 |
I4 | 124 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 7*6*4 |
I5 | 125 | 60 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 4*3*2.5 |
I6 | 126 | 51 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1bN0M0 | IB | Malignant | 8*4.5*4.5 |
I7 | 127 | 51 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 4*3 |
I8 | 128 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 4*2.5*1.5 |
I9 | 129 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3*1.2 |
I10 | 130 | 43 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3*2.5 |
I11 | 131 | 66 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | * |
I12 | 132 | 63 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | * |
I13 | 133 | 55 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1bN0M0 | IB | Malignant | * |
I14 | 134 | 52 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T2bN0M0 | IIB | Malignant | * |
I15 | 135 | 35 | F | Uterus | Endometrioid adenocarcinoma | 3--4 | T3aN0M0 | IIIA | Malignant | * |
J1 | 136 | 64 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1aN0M0 | IA | Malignant | 4*4 |
J2 | 137 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3*2*1 |
J3 | 138 | 49 | F | Uterus | Endometrioid adenocarcinoma | 3 | T2N0M0 | II | Malignant | 5*5*4 |
J4 | 139 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 7*6*4 |
J5 | 140 | 60 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1aN0M0 | IA | Malignant | 4*3*2.5 |
J6 | 141 | 51 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T1bN0M0 | IB | Malignant | 8*4.5*4.5 |
J7 | 142 | 51 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | 4*3 |
J8 | 143 | 53 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 4*2.5*1.5 |
J9 | 144 | 62 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3*1.2 |
J10 | 145 | 43 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | 3.5*3*2.5 |
J11 | 146 | 66 | F | Uterus | Endometrioid adenocarcinoma | 3 | T3aN0M0 | IIIA | Malignant | * |
J12 | 147 | 63 | F | Uterus | Endometrioid adenocarcinoma | 3 | T1bN0M0 | IB | Malignant | * |
J13 | 148 | 55 | F | Uterus | Endometrioid adenocarcinoma (degeneration and necrosis) | * | T1bN0M0 | IB | Malignant | * |
J14 | 149 | 52 | F | Uterus | Endometrioid adenocarcinoma with necrosis | 3 | T2bN0M0 | IIB | Malignant | * |
J15 | 150 | 35 | F | Uterus | Endometrioid adenocarcinoma | 3--4 | T3aN0M0 | IIIA | Malignant | * |
Tissue Marker |